Skip to main content
. 2025 Jun 25;111(10):6755–6761. doi: 10.1097/JS9.0000000000002846

Figure 1.

Figure 1.

Prognostic significance and immunotherapy efficacy prediction of KCTD9. (A). Cox regression analysis of KCTD9 on OS for pan-cancer was depicted via forest diagram. (B-C) The correlation between KCTD9 expression and TMB or MSI. (D) A comparison of KCTD9 mRNA expression levels between normal and colon tumor patients. (E) CD8-positive α-β T-cell activation pathway was enriched in KCTD9-related COAD in the GO-BP category; NES, normalized enrichment score.